Compass Pathways
The Director, Payer Analytics at Compass Pathways supports the commercialization of COMP360 by analyzing payer coverage, reimbursement, and access trends. The role involves generating insights on payer behavior, formulary decisions, and contracting dynamics to optimize patient access and revenue.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2016
Compass Pathways is a biotechnology company developing psilocybin-based therapies for treatment-resistant depression and other serious mental health conditions. It conducts clinical research and develops treatment models that combine psychedelic compounds with psychological support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Compass Pathways.
9% above the average for this role
BREAKING: Second Positive Phase 3 for Compass' Psilocybin, Though Modest Magnitude Raises Questions
3 weeks ago